AB BioTechnologies, Inc., a privately-held pharmaceutical contract service provider, has appointed two new executives. Bryan Hudson and Ben Lisby have joined the company as director of Quality, Validation, and IT, and director of Operations and Facilities, respectively. 

Hudson brings more than 22 years of industry experience to his new responsibilities of leading quality assurance, quality control, validation, and information technology initiatives. In addition, Lisby brings over 18 years of pharmaceutical contract manufacturing experience in both the facilities and process equipment arenas. 

“In this time of rapid transition, AB BioTechnologies relies on dedicated team members like Bryan and Ben. They bring more than four decades of combined experience to our team. Their capable leadership will ensure our expansion is quality from the ground up,” said Dr. Jeff Schwegman, chief executive officer and founder.